The Covid Vaccine Windfall Turns on Pfizer and Moderna
Opinion by Allysia Finley • 1hT
The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a creature from the Black Lagoon. Public-health officials indicated we’d need another updated booster. Share prices in Pfizer and Moderna surged.
By month’s end, Pfizer’s stock-market value had surpassed $300 billion, up 50% from the start of the pandemic. Moderna’s shares had soared by more than 1,000% over the same period. In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill. READ MORE AT The Covid Vaccine Windfall Turns on Pfizer and Moderna (msn.com)
Subscribe to:
Post Comments (Atom)
-
Welcome to The New Everything Croton, a collection of all things Croton--our history, our homes, our issues, our businesses, our schools, ou...
-
Welcome to The New Everything Croton, a collection of all things Croton--our history, our homes, our issues, our businesses, our schools, ou...
-
Welcome to The New Everything Croton--a collection of all things Croton, our history, our homes, our issues, our houses of worship--in short...
No comments:
Post a Comment